Astragaloside IV inhibits migration and invasion in human lung cancer A549 cells via regulating PKC-α-ERK1/2-NF-κB pathway
- 1 November 2014
- journal article
- Published by Elsevier BV in International Immunopharmacology
- Vol. 23 (1), 304-313
- https://doi.org/10.1016/j.intimp.2014.08.027
Abstract
No abstract availableKeywords
Funding Information
- Suzhou Science and Technology Program (ZXY2012009)
- College Graduate Research and Innovation Project of Jiangsu Province (CXLX13_599)
This publication has 46 references indexed in Scilit:
- Inhibition of protein kinase C α/βII and activation of c-Jun NH2-terminal kinase mediate glycyrrhetinic acid induced apoptosis in non-small cell lung cancer NCI-H460 cellsBioorganic & Medicinal Chemistry Letters, 2014
- ERKs in Cancer: Friends or Foes?Cancer Research, 2014
- Loss of E-cadherin activates EGFR-MEK/ERK signaling, which promotes invasion via the ZEB1/MMP2 axis in non-small cell lung cancerOncotarget, 2013
- Key molecular mechanisms in lung cancer invasion and metastasis: A comprehensive reviewCritical Reviews in Oncology/Hematology, 2013
- Quercetin abrogates IL-6/STAT3 signaling and inhibits glioblastoma cell line growth and migrationExperimental Cell Research, 2012
- The Biology of Protein Kinase CAdvances in Experimental Medicine and Biology, 2012
- PKC and the control of localized signal dynamicsNature Reviews Molecular Cell Biology, 2010
- Plasma protein kinase C (PKC)α as a biomarker for the diagnosis of cancersCarcinogenesis: Integrative Cancer Research, 2009
- Effect of staurosporine on the mobility and invasiveness of lung adenocarcinoma A549 cells: an in vitro studyBMC Cancer, 2009
- Astragalus-Based Chinese Herbs and Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Meta-Analysis of Randomized TrialsJournal of Clinical Oncology, 2006